NSE · AKUMS
Akums Drugs and Pharmaceuticals Limited (AKUMS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#558
of 5,047 stocks
▼ 131W▼ 31M
Peak #525 · 02 Oct 2026
A midcap name in Healthcare, Akums Drugs and Pharmaceuticals Limited remains firmly promoter-controlled, with promoters holding 75%, is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
11,057.24 Cr
P/E Ratio
43.32
P/B Ratio
3.32
ROE
7.70%
ROCE
11.40%
Dividend Yield
0.28%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 1,342.39 Cr | 1,166.63 Cr | 1,157.87 Cr | 1,159.59 Cr |
| Net Profit | 114.56 Cr | 100.98 Cr | 81.34 Cr | 67.67 Cr |
| EPS | 7.37 | 6.53 | 5.53 | 4.33 |
| Operating Profit | 180.42 Cr | 163.99 Cr | 146.90 Cr | 141.54 Cr |
Shareholding pattern
Promoter
75.26%
Public
22.01%
PUBLIC BREAKDOWN
FII
1.15%
DII
14.40%
MF (within DII)
11.23%
Individuals
5.65%
Mutual fund holdings
₹817.18
Cr total
20
Schemes
10
Fund Houses
₹817.18 Cr
Total Exposure
Franklin Templeton Mutual Fund₹449.10 Cr (55.0%)
Bandhan Mutual Fund₹129.83 Cr (15.9%)
ICICI Prudential Mutual Fund₹117.21 Cr (14.3%)
Nippon India Mutual Fund₹98.90 Cr (12.1%)
JioBlackRock Mutual Fund₹11.23 Cr (1.4%)
Others₹10.90 Cr (1.3%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 03 Jul 2026 | Dividend | Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.